Hepatic and Cardiac Iron-load in Children on Long-term Chelation with Deferiprone for Thalassemia Major
![PDF) Effects of Renal Impairment on the Pharmacokinetics of Orally Administered Deferiprone: Deferiprone in patients with renal impairment PDF) Effects of Renal Impairment on the Pharmacokinetics of Orally Administered Deferiprone: Deferiprone in patients with renal impairment](https://www.researchgate.net/publication/303874231/figure/tbl1/AS:614196282683401@1523447213130/figure-tbl1_Q320.jpg)
PDF) Effects of Renal Impairment on the Pharmacokinetics of Orally Administered Deferiprone: Deferiprone in patients with renal impairment
![The pharmacokinetic and safety profile of single-dose deferiprone in subjects with sickle cell disease | SpringerLink The pharmacokinetic and safety profile of single-dose deferiprone in subjects with sickle cell disease | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00277-021-04728-0/MediaObjects/277_2021_4728_Fig1_HTML.png)
The pharmacokinetic and safety profile of single-dose deferiprone in subjects with sickle cell disease | SpringerLink
![Mean ± SE plasma concentration (µg/mL) of deferiprone on ordinary scale... | Download Scientific Diagram Mean ± SE plasma concentration (µg/mL) of deferiprone on ordinary scale... | Download Scientific Diagram](https://www.researchgate.net/publication/223988164/figure/fig2/AS:341694605217810@1458477750629/Mean-SE-plasma-concentration-g-mL-of-deferiprone-on-ordinary-scale-after-oral-dose.png)
Mean ± SE plasma concentration (µg/mL) of deferiprone on ordinary scale... | Download Scientific Diagram
![a Cumulative % dose of deferiprone and b deferiprone 3-O-glucuronide... | Download Scientific Diagram a Cumulative % dose of deferiprone and b deferiprone 3-O-glucuronide... | Download Scientific Diagram](https://www.researchgate.net/publication/357571933/figure/fig2/AS:1119587496149029@1643941868799/a-Cumulative-dose-of-deferiprone-and-b-deferiprone-3-O-glucuronide-excreted-following-a.png)
a Cumulative % dose of deferiprone and b deferiprone 3-O-glucuronide... | Download Scientific Diagram
![a Cumulative % dose of deferiprone and b deferiprone 3-O-glucuronide... | Download Scientific Diagram a Cumulative % dose of deferiprone and b deferiprone 3-O-glucuronide... | Download Scientific Diagram](https://www.researchgate.net/publication/357571933/figure/fig2/AS:1119587496149029@1643941868799/a-Cumulative-dose-of-deferiprone-and-b-deferiprone-3-O-glucuronide-excreted-following-a_Q320.jpg)
a Cumulative % dose of deferiprone and b deferiprone 3-O-glucuronide... | Download Scientific Diagram
![Brain iron chelation by deferiprone in a phase 2 randomised double-blinded placebo controlled clinical trial in Parkinson's disease | Scientific Reports Brain iron chelation by deferiprone in a phase 2 randomised double-blinded placebo controlled clinical trial in Parkinson's disease | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-017-01402-2/MediaObjects/41598_2017_1402_Fig1_HTML.jpg)
Brain iron chelation by deferiprone in a phase 2 randomised double-blinded placebo controlled clinical trial in Parkinson's disease | Scientific Reports
![Ferriprox Twice-a-Day Tablet Dosing Approved for Transfusional Iron Overload Due to Thalassemia Syndromes Ferriprox Twice-a-Day Tablet Dosing Approved for Transfusional Iron Overload Due to Thalassemia Syndromes](https://www.empr.com/wp-content/uploads/sites/7/2020/05/Ferriprox-deferiprone-Chiesi.jpg)
Ferriprox Twice-a-Day Tablet Dosing Approved for Transfusional Iron Overload Due to Thalassemia Syndromes
![Deferiprone in the treatment of transfusion-dependent thalassemia: a review and perspective | Semantic Scholar Deferiprone in the treatment of transfusion-dependent thalassemia: a review and perspective | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/ae06f99bc06eeb410789b1afade7ecf1383fa955/3-Figure2-1.png)
Deferiprone in the treatment of transfusion-dependent thalassemia: a review and perspective | Semantic Scholar
![Deferiprone vs deferoxamine for transfusional iron overload in SCD and other anemias: a randomized, open-label noninferiority study - ScienceDirect Deferiprone vs deferoxamine for transfusional iron overload in SCD and other anemias: a randomized, open-label noninferiority study - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2473952921008302-grabsf1.jpg)
Deferiprone vs deferoxamine for transfusional iron overload in SCD and other anemias: a randomized, open-label noninferiority study - ScienceDirect
![Evaluation of the efficacy and safety of deferiprone compared with deferasirox in paediatric patients with transfusion-dependent haemoglobinopathies (DEEP-2): a multicentre, randomised, open-label, non-inferiority, phase 3 trial - The Lancet Haematology Evaluation of the efficacy and safety of deferiprone compared with deferasirox in paediatric patients with transfusion-dependent haemoglobinopathies (DEEP-2): a multicentre, randomised, open-label, non-inferiority, phase 3 trial - The Lancet Haematology](https://www.thelancet.com/cms/asset/db564498-0f86-4d73-82ee-18ffa7349a65/gr2.jpg)